By Abbott Labs
Report updated Apr 23, 2026
FreeStyle LibreLink - US
For individuals with diabetes who use FreeStyle Libre sensors and require a digital tool to track and share glucose data.
FreeStyle LibreLink - US is a struggling medical app that is completely free. With a 2.9/5 rating from 3.3K reviews, it struggles with user retention. Users particularly appreciate hardware quality, though os & device compatibility remains a common concern.
What is FreeStyle LibreLink - US?
Current Momentum
v2.13 · 1w ago
MaintenanceFreeStyle LibreLink - US is currently in maintenance mode with no recent major feature updates identified.
Active Nemesis
Dexcom G7
By Dexcom
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Painless glucose monitoring by holding the phone near a sensor, replacing routine fingersticks.
Generates detailed glucose reports and visual patterns to help users understand health trends.
Connects and shares glucose data directly with healthcare professionals.
How much does it cost?
- Free app usage with required hardware sensor purchase
The app follows a hardware-companion model where monetization is entirely dependent on the recurring purchase of physical sensors rather than digital subscriptions.
Who Built It?
Abbott Labs
Providing digital health tools for continuous glucose monitoring. Enabling patients to track glucose trends via smartphone integration.
Portfolio
13
Apps
Who is Abbott Labs?
Abbott Labs operates as a specialized medical technology provider, leveraging proprietary hardware-software integration to maintain a dominant position in the diabetes management market. Their strategic moat is built on the mandatory pairing of their mobile applications with specific, regulated glucose-sensing hardware, creating high switching costs for the end user. The current trajectory is defined by a critical technical inflection point, as recent performance issues on newer iOS versions threaten the stability of their primary digital touchpoints.
Who is Abbott Labs for?
- Individuals with diabetes
- Their caregivers requiring real-time glucose data
- Trend analysis
Portfolio momentum
Released 4 updates across 3 apps in the last 6 months, maintaining a consistent focus on their core medical monitoring suite.
What other apps does Abbott Labs make?
Libre by Abbott
FreeStyle Libre 3 – US
FreeStyle LibreLink – ZA
FreeStyle LibreLink – BE
FreeStyle LibreLink – KW
FreeStyle Libre 3 - CH
What do users think recently?
High confidence · Latest 100 of 3.3K total reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a upset sentiment. Users appreciate hardware quality, but report os & device compatibility and app performance & stability.
What Users Love
What Frustrates Users
What is the competitive landscape for FreeStyle LibreLink - US?
How's The Medical Market?
Market outlook for this category
Available very soon
The rivals identified
The Nemesis
Dexcom G7
★3.3 (12.2K)Dexcom
⚡The primary hardware-software rival in the CGM space, maintaining a higher release velocity and significantly higher user sentiment for its next-gen sensor integration.
Head to Head
The target app must prioritize background Bluetooth stability and Apple Watch complications to match Dexcom's 'glanceable' UX, or risk losing the premium user segment.
What sets FreeStyle LibreLink - US apart
Broader compatibility with legacy 10-day and 14-day sensors, providing a wider hardware entry point for budget-conscious users.
Simpler, scan-on-demand UX that appeals to users who prefer intermittent checking over constant Bluetooth streaming.
What's Dexcom G7's Edge
Predictive 'Urgent Low Soon' alerts that give users a 20-minute warning before a hypoglycemic event occurs.
Superior release cadence (3 updates in 6 months) focusing on connectivity stability, addressing the 'signal loss' complaints prevalent in the target app.
Contenders
Positions as a holistic chronic condition manager (diabetes, hypertension, weight) rather than a single-purpose glucose monitor.
Includes access to live health coaches and personalized journeys, moving beyond data visualization into behavioral change.
mySugr - Diabetes Tracker Log
★4.5 (134.1K)mySugr GmbH
⚡A dominant software-only player that excels in engagement through gamification and high-frequency updates (14 in 6 months).
Features a 'Diabetes Monster' gamification mechanic that rewards users for frequent logging, driving higher retention than the target's utility-first UI.
Includes a built-in Bolus Calculator (in approved regions) that translates glucose data directly into insulin dosage recommendations.
Glooko - Track Diabetes Data
★4.6 (8.8K)Glooko, Inc.
⚡The leading hardware-agnostic aggregator that positions itself as the 'universal' dashboard for clinical data sharing.
Syncs data from over 80+ different insulin pumps, meters, and CGMs, allowing users to switch hardware without losing historical data.
Optimized for provider-facing reports, offering a more robust PDF export engine for endocrinologist visits than the target app.
OneTouch Reveal® app
★4.8 (158K)LifeScan, Inc.
📈A high-scale rival focusing on the Blood Glucose Meter (BGM) ecosystem with a massive established user base.
Uses 'ColorSure' technology to automatically categorize readings into color-coded zones (low, in-range, high) for instant visual feedback.
Deeply integrated with LifeScan hardware, offering automated data fetching from Bluetooth-enabled meters without manual scanning.
Peers
Uses a unique 'Calendar Sync' workaround to display glucose levels on Tesla dashboards and various smart home devices.
Provides an automated 'Emergency Contact' system that can place a phone call to a caregiver if a user's glucose drops too low at night.
Happy Bob
★4.7 (1K)Harald AI
🚀A personality-driven overlay for CGM data designed to reduce 'diabetes burnout' through humor.
Offers a customizable 'personality' for alerts (e.g., snarky, supportive, or professional) to make glucose management feel less clinical.
Aggregates CGM data into a 'Star' reward system to incentivize users to stay within their target range.
Omnipod 5 App
★3.5 (1.5K)Insulet Corporation
📈A critical ecosystem player for users on automated insulin delivery (AID) systems.
Directly controls insulin delivery from a smartphone, a high-stakes feature the target app does not support.
Integrates CGM data directly into an automated algorithm to adjust insulin doses in real-time.
New Kids on the Block
Gluroo Diabetes Logger
★4.4 (2.2K)Gluroo Imaginations Inc.
⚡A rising threat focusing on 'Collaborative Care' with a high update frequency in early 2026.
Uses a 'Diabetes Group Chat' UI where family members can coordinate care, log meals, and confirm insulin doses in a shared thread.
Implements a 'Smart IOB' (Insulin on Board) tracker that works across multiple caregivers to prevent double-dosing.
SNAQ - Diabetes Food Tracker
★4.6 (2.6K)SNAQ GmbH
⚡An AI-first companion that solves the 'carb counting' pain point which the target app leaves to manual entry.
Uses computer vision to calculate macronutrients from a single photo of a meal, syncing the data directly to glucose charts.
Provides a 'Meal Discovery' feature that shows how similar past meals affected the user's glucose levels based on CGM history.
The outtake for FreeStyle LibreLink - US
Strengths to defend, gaps to attack
Core Strengths
- Proprietary NFC scanning technology
- Direct clinical integration via LibreView
- Strong hardware-software synergy
Critical Frictions
- Critical iOS 18/iPhone 16 compatibility issues
- Severe UI lag and performance degradation
- Missing Dark Mode and Apple Health integration
Growth Levers
- Native Apple Watch support to match Dexcom
- AI meal tracking integration (SNAQ model)
- Collaborative care features (Gluroo model)
Market Threats
- Dexcom G7's superior update velocity and 30-min warm-up
- User churn due to technical instability on new devices
- Hardware-agnostic aggregators capturing the data layer
What are the next best moves?
Immediate Hotfix for iOS 18 & iPhone 16 Compatibility
This is the #1 complaint theme and a total blocker for users on new hardware, leading to a 'terrible' sentiment rating.
Implement Apple Health & Apple Watch Integration
Dexcom G7 offers native Watch support and users explicitly cite the lack of Apple Health as a major frustration.
Performance Optimization Sprint
Users report 30-second input lags and frequent freezing, indicating severe technical debt or memory leaks.
Feature Gaps vs Competitors
- Native Apple Watch integration (available in Dexcom G7)
- 30-minute sensor warm-up (Dexcom G7 has this; LibreLink requires 60 mins)
- AI Food Tracking/Computer Vision (available in SNAQ)
- Bolus Calculator (available in mySugr)
Key Takeaways
FreeStyle LibreLink is currently a high-quality hardware product trapped in a failing software wrapper. While the NFC scanning remains a core strength, the app's inability to support current iOS versions and its lack of modern ecosystem features (Watch/Health) make it highly vulnerable to Dexcom G7.
Where Is It Heading?
Declining
Critical failures on iOS 18 and iPhone 16 reported by high volume of users.
Severe performance lag (30s input delay) suggesting unaddressed technical debt.
Recent updates limited to generic bug fixes with no new feature expansion.